28 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Sierra Oncology, Inc. SRRA shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic, anemic, and previously treated with an FDA-approved JAK inhibitor. The company also entered into a term loan agreement with Oxford Finance LLC to support the commercial preparation and potential launch of momelotinib.
• Aptorum Group Limited APM shares jumped 29.1% to $2.0907 after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a repurposed small molecule compound for Neuroblastoma.
• Bally's Corporation BALY gained 21% to $35.35. Standard General, Bally's largest shareholder, submitted proposal to acquire all of the outstanding shares of Bally's common stock not currently owned by the company at a price of $38 per share.
• Turquoise Hill Resources Ltd. TRQ shares climbed 15.9% to $17.50. Rio Tinto Plc and the Mongolian government said reached an agreement to end a dispute over the Oyu Tolgoi copper-gold mining project. As part of the agreement, Turquoise Hill Resources will waive debt worth $2.4 billion owed to it by Mongolia.
• Checkpoint Therapeutics, Inc. CKPT gained 13.7% to $2.4894 after reporting topline results from registration-enabling trial of cosibelimab in metastatic cutaneous squamous cell carcinoma. HC Wainwright & Co. maintained Checkpoint Therapeutics with a Buy and raised the price target from $17 to $26.
• Sonder Holdings Inc. SOND rose 11.8% to $8.00. JMP Securities, on Monday, initiated coverage on Sonder Holdings with a Market Outperform rating and announced a price target of $12.
• Virgin Orbit Holdings, Inc. VORB jumped 11.8% to $7.61 after dropping 18% on Monday.
• Allscripts Healthcare Solutions, Inc. MDRX gained 10.8% to $19.38. Allscripts Healthcare Solutions expects Q4 revenue of $390 million - $395 million, better than the consensus of $$386.75 million. SVB Leerink upgraded Allscripts Healthcare from Market Perform to Outperform and raised the price target from $19 to $22.
• Capricor Therapeutics, Inc. CAPR rose 9.9% to $3.11. Capricor Therapeutics said it has entered into a partnership with Japanese pharma company Nippon Shinyaku for the exclusive commercialization and distribution in the U.S. of Capricor's lead asset, CAP-1002, for the treatment of Duchenne muscular dystrophy.
• Vertical Aerospace Ltd. EVTL jumped 9.4% to $8.23.
• Fluidigm Corporation FLDM surged 9% to $3.25. Fluidigm approved a $250 million investment by Casdin Capital LLC and Viking Global Investors LP with zero-coupon convertible preferred shares with a conversion price of $3.40/share.
• Amarin Corporation plc AMRN gained 8.2% to $3.2350.
• Telefonaktiebolaget LM Ericsson ERIC rose 6.1% to $11.56 after reporting upbeat core earnings for its fourth quarter.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these penny stocks insiders are buying

Losers

• Aerojet Rocketdyne Holdings, Inc. AJRD dropped 14.4% to $38.54. Aerojet Rocketdyne on Lockheed Transaction said, 'We believe it is highly likely that the FTC will vote to sue to block the transaction and expect they will make a decision before Jan. 27, 2022.'
• Inhibrx, Inc. INBX shares fell 13.6% to $22.35. The company, earlier during the month, announced initial results from Part 3 (combination dose escalation) of the Phase 1 trial of INBRX-106 combined with Keytruda for solid tumors.
• Kidpik Corp. PIK dipped 12.8% to $6.19.
• AMTD International Inc. HKIB fell 11.8% to $3.79 after dropping over 15% on Monday.
• HashiCorp, Inc. HCP dipped 11.5% to $54.92.
• Instil Bio, Inc. TIL fell 10.2% to $12.04.
• Comstock Resources, Inc. CRK dropped 10% to $7.05.
• IGM Biosciences, Inc. IGMS dipped 9.7% to $17.95.
• BT Brands, Inc. BTBD fell 9.7% to $2.80 after climbing around 28% on Monday.
• Vertex Energy, Inc. VTNR fell 9.4% to $3.8250. Clean Harbors and Vertex Energy mutually agreed to terminate planned acquisition of Vertex’s used motor oil collection and re-refining assets.
• General Electric Company GE dipped 8% to $89.20 after the company reported worse-than-expected Q4 sales results.
• NeuroBo Pharmaceuticals, Inc. NRBO fell 7.7% to $1.08 after gaining around 5% on Monday.
• Shopify Inc. SHOP dropped 7.4% to $868.48 after Keybanc lowered its price target on the stock from $1750 to $1250.
• Xerox Holdings Corporation XRX fell 6.8% to $19.56. Xerox reported a fourth-quarter FY21 sales decline of 7.9% year-on-year, to $1.78 billion, missing the consensus of $1.82 billion.
• Pintec Technology Holdings Limited PT fell 6.4% to $0.6160 after dipping more than 52% on Monday.